JPWO2023002939A1 - - Google Patents

Info

Publication number
JPWO2023002939A1
JPWO2023002939A1 JP2023536733A JP2023536733A JPWO2023002939A1 JP WO2023002939 A1 JPWO2023002939 A1 JP WO2023002939A1 JP 2023536733 A JP2023536733 A JP 2023536733A JP 2023536733 A JP2023536733 A JP 2023536733A JP WO2023002939 A1 JPWO2023002939 A1 JP WO2023002939A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023536733A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023002939A1 publication Critical patent/JPWO2023002939A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023536733A 2021-07-19 2022-07-15 Pending JPWO2023002939A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021118968 2021-07-19
PCT/JP2022/027835 WO2023002939A1 (ja) 2021-07-19 2022-07-15 炎症性腸疾患の予防又は改善のための組成物、及び腸内細菌叢調節のための組成物

Publications (1)

Publication Number Publication Date
JPWO2023002939A1 true JPWO2023002939A1 (ru) 2023-01-26

Family

ID=84979312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536733A Pending JPWO2023002939A1 (ru) 2021-07-19 2022-07-15

Country Status (3)

Country Link
JP (1) JPWO2023002939A1 (ru)
TW (1) TW202308605A (ru)
WO (1) WO2023002939A1 (ru)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562342B1 (en) * 1998-02-06 2003-05-13 Mochida Pharmaceutical Co., Ltd. Preventives/remedies for inflammatory intestinal disease
EP2370084B1 (en) * 2008-12-02 2014-10-22 Prolacta Bioscience, Inc. Human milk permeate compositions and methods of making and using same
US10426765B2 (en) * 2012-06-15 2019-10-01 Conaris Research Institute Ag Pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
US10857128B2 (en) * 2017-09-19 2020-12-08 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Methods and compositions for treating inflammatory diseases
US20230063703A1 (en) * 2020-02-18 2023-03-02 Keio University Drug and food for treating and/or preventing enteritis and/or hepatitis

Also Published As

Publication number Publication date
WO2023002939A1 (ja) 2023-01-26
TW202308605A (zh) 2023-03-01

Similar Documents

Publication Publication Date Title
BR112021014123A2 (ru)
BR112022009896A2 (ru)
JPWO2021167032A1 (ru)
BR112022024743A2 (ru)
BR112023006729A2 (ru)
BR102021018859A2 (ru)
BR102021015500A2 (ru)
BR102021007058A2 (ru)
BR102020022030A2 (ru)
JPWO2023002939A1 (ru)
BR112023004146A2 (ru)
BR112023008976A2 (ru)
BR102021020147A2 (ru)
BR102021018926A2 (ru)
BR102021018167A2 (ru)
BR102021016837A2 (ru)
BR102021016551A2 (ru)
BR102021016375A2 (ru)
BR102021016176A2 (ru)
BR102021016200A2 (ru)
BR102021015566A2 (ru)
BR102021015450A8 (ru)
BR102021015247A2 (ru)
BR102021015220A2 (ru)
BR102021014056A2 (ru)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231024